{"database":"iProX","file_versions":[],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Wei Long"],"species":["Mus Musculus"],"full_dataset_link":["http://www.iprox.org/page/project.html?id=IPX0018153000"],"submitter_email":["3028463099@qq.com"],"submitter_affiliation":["Kunming Medical University"],"sample_protocol":[""],"repository":["iProX"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Anlotinib Treatment of Papillary Thyroid Carcinoma via Inhibition of EGFR","description":"This study explored the therapeutic effect and molecular mechanisms of anlotinib in a model of papillary thyroid carcinoma (PTC) with BRAFV600E and TERT promoter cooccurring mutations, providing a theoretical basis for identifying biomarkers for predicting the effectiveness of anlotinib treatment in radioactive iodine refractory (RAIR)-PTC.","dates":{"publication":"Mon Jul 13 00:00:00 BST 2026"},"accession":"PXD081018","cross_references":{"TAXONOMY":["10090"]}}